Name | Number of supported studies | Average coverage | |
---|---|---|---|
erythrocyte | 3 studies | 33% ± 13% |
Insufficient scRNA-seq data for expression of PRC1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 90% | 934.15 | 1295 / 1445 | 36% | 0.56 | 66 / 183 |
ovary | 98% | 519.58 | 176 / 180 | 16% | 0.24 | 69 / 430 |
stomach | 91% | 540.30 | 328 / 359 | 21% | 0.32 | 59 / 286 |
intestine | 90% | 625.39 | 871 / 966 | 19% | 0.28 | 98 / 527 |
skin | 100% | 2760.66 | 1801 / 1809 | 1% | 0.01 | 3 / 472 |
breast | 100% | 442.25 | 457 / 459 | 1% | 0.01 | 6 / 1118 |
lung | 96% | 567.03 | 556 / 578 | 4% | 0.05 | 45 / 1155 |
spleen | 100% | 672.57 | 240 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 525.65 | 1312 / 1335 | 0% | 0 | 0 / 0 |
uterus | 95% | 367.50 | 162 / 170 | 3% | 0.04 | 13 / 459 |
bladder | 90% | 263.76 | 19 / 21 | 7% | 0.10 | 35 / 504 |
adipose | 96% | 440.18 | 1152 / 1204 | 0% | 0 | 0 / 0 |
prostate | 88% | 269.69 | 215 / 245 | 0% | 0 | 0 / 502 |
thymus | 85% | 268.77 | 557 / 653 | 0% | 0 | 0 / 605 |
brain | 82% | 479.21 | 2167 / 2642 | 1% | 0.01 | 4 / 705 |
pancreas | 81% | 249.71 | 267 / 328 | 1% | 0.01 | 1 / 178 |
adrenal gland | 78% | 311.89 | 202 / 258 | 0% | 0 | 0 / 230 |
heart | 65% | 208.45 | 560 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 59% | 1567.93 | 545 / 929 | 0% | 0 | 0 / 0 |
kidney | 48% | 178.24 | 43 / 89 | 0% | 0.00 | 1 / 901 |
muscle | 34% | 78.82 | 277 / 803 | 0% | 0 | 0 / 0 |
liver | 15% | 93.86 | 33 / 226 | 0% | 0 | 0 / 406 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0000022 | Biological process | mitotic spindle elongation |
GO_0051301 | Biological process | cell division |
GO_0051256 | Biological process | mitotic spindle midzone assembly |
GO_0000226 | Biological process | microtubule cytoskeleton organization |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0032465 | Biological process | regulation of cytokinesis |
GO_0005876 | Cellular component | spindle microtubule |
GO_0030496 | Cellular component | midbody |
GO_0005886 | Cellular component | plasma membrane |
GO_0000922 | Cellular component | spindle pole |
GO_0005654 | Cellular component | nucleoplasm |
GO_1990023 | Cellular component | mitotic spindle midzone |
GO_0045171 | Cellular component | intercellular bridge |
GO_0070938 | Cellular component | contractile ring |
GO_0005829 | Cellular component | cytosol |
GO_0015630 | Cellular component | microtubule cytoskeleton |
GO_0005737 | Cellular component | cytoplasm |
GO_0005694 | Cellular component | chromosome |
GO_0005819 | Cellular component | spindle |
GO_0005634 | Cellular component | nucleus |
GO_0019901 | Molecular function | protein kinase binding |
GO_0008017 | Molecular function | microtubule binding |
GO_0005515 | Molecular function | protein binding |
GO_0019894 | Molecular function | kinesin binding |
Gene name | PRC1 |
Protein name | Protein regulator of cytokinesis 1 |
Synonyms | |
Description | FUNCTION: Key regulator of cytokinesis that cross-links antiparrallel microtubules at an average distance of 35 nM. Essential for controlling the spatiotemporal formation of the midzone and successful cytokinesis. Required for KIF14 localization to the central spindle and midbody. Required to recruit PLK1 to the spindle. Stimulates PLK1 phosphorylation of RACGAP1 to allow recruitment of ECT2 to the central spindle. Acts as an oncogene for promoting bladder cancer cells proliferation, apoptosis inhibition and carcinogenic progression . . |
Accessions | O43663 ENST00000361188.9 [O43663-4] ENST00000557905.5 G3V3N7 H3BSJ8 H0YNE4 ENST00000442656.6 [O43663-3] ENST00000556972.6 ENST00000560423.5 ENST00000559811.1 H0YM42 H0YLA0 ENST00000394249.8 [O43663-1] H0YL53 ENST00000555455.5 ENST00000559828.1 |